Jagpreet Chhatwal, PhD is a senior scientist at the Institute for Technology Assessment at Massachusetts General Hospital, and an assistant professor at Harvard Medical School. His research focuses on the application of mathematical modeling to inform health policies. He leads health outcomes and cost-effectiveness projects in multiple disease areas including hepatitis C, hepatocellular carcinoma, and liver transplantation. Dr. Chhatwal’s recent research on hepatitis C has informed several highly-debated questions surrounding the cost-effectiveness of hepatitis C screening and treatments in the United States, India and elsewhere. His work has been featured in leading media such as The Wall Street Journal, Forbes, and National Public Radio. He currently serves as a cost-effectiveness and decision analysis editor of Clinical Gastroenterology and Hepatology.